Mannatech, Incorporated (MTEX 1.94, +0.09, +4.86%) , a leading developer and provider of nutritional supplements and skin care products based on Real Food Technology(SM) solutions, announced the Australian Patent Office has granted the company a patent for technology related to its Ambrotose AO(R) product.
With the issuance of this new patent, Mannatech now holds 12 patents for technology related to Ambrotose AO in Australia, Mexico, New Zealand, Singapore, South Africa and South Korea.
"As a company based in scientific development, we consider our intellectual property to be one of our most valuable corporate assets," said Robert A. Sinnott, Ph.D., MNS, co-CEO and chief science officer of Mannatech. "Ambrotose AO technology has been granted patents consistently from governing bodies around the world; thus, validating the diligence and scientific research we put behind this important product for health and wellness."
Mannatech currently holds 63 patents in 30 countries for its health-related technologies.
Many of Mannatech's products are based on Real Food Technology solutions, which provide consumers with products that contain standardized levels of natural and plant-sourced nutrients. Food-sourced ingredients are chosen from those scientifically proven to most benefit the human body.
Mannatech, Incorporated, develops high-quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. These proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan, Taiwan, Singapore and the Republic of Korea. For more information, visit mannatech.com.